GWS
NKTR icon

Glassman Wealth Services’s Nektar Therapeutics NKTR Stock Holding History

Glassman Wealth Services’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed – – 2005
2022
Q3 		$0 Sell
2
-328
-99% -$19.5K ﹤0.01% 1881
2022
Q2 		$19K Buy
330
+327
+10,900% +$20.6K ﹤0.01% 644
2022
Q1 		$0 Sell
3
-2
-40% -$296 ﹤0.01% 1847
2021
Q4 		$1K Sell
5
-57
-92% -$12.4K ﹤0.01% 1434
2021
Q3 		$17K Sell
62
-21
-25% -$5.05K ﹤0.01% 632
2021
Q2 		$21K Buy
83
+21
+34% +$5.81K ﹤0.01% 562
2021
Q1 		$18K Sell
62
-7
-10% -$2.18K ﹤0.01% 556
2020
Q4 		$18K Buy
69
+21
+44% +$5.43K ﹤0.01% 560
2020
Q3 		$12K Buy
48
+27
+129% +$8.49K ﹤0.01% 574
2020
Q2 		$7K Buy
21
+20
+2,000% +$6.24K ﹤0.01% 561
2020
Q1 		$0 Buy
+1
New +$309 ﹤0.01% 1407
2019
Q3 		– Sell
-1
Closed – – 1266
2019
Q2 		$0 Buy
+1
New +$501 ﹤0.01% 1268
2019
Q1 		– Hold
0
– – – 1151
2018
Q4 		– Hold
0
– – – 908
2018
Q3 		– Hold
0
– – – 910
2018
Q2 		– Hold
0
– – – 900
2018
Q1 		– Hold
0
– – – 641
2017
Q4 		– Hold
0
– – – 750

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Glassman Wealth Services's NKTR Position: Q4 2022 in Review

Glassman Wealth Services sold out of Nektar Therapeutics (NKTR) in Q4 2022, closing a stake of 2 shares.

Glassman Wealth Services first reported a position in NKTR in Q2 2019 and held it in 12 quarters. The position peaked at $21K in Q2 2021. 214 funds tracked by Wall St. Rank hold NKTR as of Q4 2022.

  • Glassman Wealth Services reported no remaining Nektar Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Glassman Wealth Services sold 2 Nektar Therapeutics shares in Q4 2022.
  • Glassman Wealth Services first reported a position in Nektar Therapeutics in Q2 2019 and held it in 12 quarters.
  • Glassman Wealth Services's Nektar Therapeutics position peaked at $21K in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2022.

Based on Glassman Wealth Services's 13F filing for Q4 2022, filed 6 Feb 2023.